Self‐Cascade API Nanozyme for Synergistic Anti‐Inflammatory, Antioxidant, and Ferroptosis Modulation in the Treatment of Corneal Neovascularization (Small 17/2025)
Source abstract
Abstract
Corneal Neovascularization In article number 2407751, Hua Gao and co-workers designed a self-cascade active pharmaceutical ingredient nanozyme to combat corneal neovascularization, a condition that can severely impair vision. The nanozyme demonstrates the ability to inhibit reactive oxygen species, reduce inflammatory cytokines, and modulate ferroptosis, highlighting its potential as a safe and effective treatment for ocular inflammatory diseases.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Selenium in Biological Systems · Sulfur Compounds in Biology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory Cultivation Base Shandong Key Laboratory of Eye Diseases Eye Institute of Shandong First Medical University Qingdao 266071 China
School of Ophthalmology Shandong First Medical University Jinan 250062 China
The Affiliated Women's and Children's Hospital of Ningbo University Ningbo 315000 China
Medical College Qingdao University Qingdao 266073 China
Eye Hospital of Shandong First Medical University Jinan 250117 China
References
Reference metadata was not supplied for this record.